Showing results (321-330 of 498) with videos related to
Sort By:
Pageof 50
Investigational New Drugs|August 27, 2013
A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomasSeok Jin Kim, Hye Jin Kang, Jin Seok Kim, et al.Hematological Oncology|June 4, 2016
Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative studyMonica Bellei, Elena Sabattini, Emanuela Anna Pesce, et al.Oncotarget|October 21, 2016
Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab eraSeyoung Seo, Jung Yong Hong, Shinkyo Yoon, et al.The Lancet. Haematology|December 22, 2015
Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trialDaryl Tan, Colin Phipps, William Y K Hwang, et al.Blood|April 3, 2007
The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphomaSarah Park, Jeeyun Lee, Young Hyeh Ko, et al.Blood Research|January 16, 2016
Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) studySeul Lee, Moon Jin Kim, Jin Seok Kim, et al.The Lancet. Haematology|December 22, 2015
Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysisSeok Jin Kim, Joon Young Choi, Seung Hyup Hyun, et al.Annals of Hematology|June 28, 2018
Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma studySung Yong Oh, Won Seog Kim, Hye-Jin Kang, et al.American Journal of Hematology|September 28, 2002
Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignanciesKihyun Kim, Mark H Lee, Jingook Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2019
Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell LymphomaLaurie H Sehn, Alex F Herrera, Christopher R Flowers, et al.Pageof 50